Articles amb requisits d'accés públic - Jim WoodgettMés informació
No estan disponibles en cap lloc: 8
Glycogen synthase kinase 3: a kinase for all pathways?
P Patel, JR Woodgett
Current topics in developmental biology 123, 277-302, 2017
Requisits: Canadian Institutes of Health Research
Glycogen synthase kinase-3β heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative …
Y Bersudsky, A Shaldubina, N Kozlovsky, JR Woodgett, G Agam, ...
Behavioural pharmacology 19 (3), 217-224, 2008
Requisits: Canadian Institutes of Health Research
Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice
FHF Lee, O Kaidanovich-Beilin, JC Roder, JR Woodgett, AHC Wong
Schizophrenia research 129 (1), 74-79, 2011
Requisits: Canadian Institutes of Health Research
Xanthatin anti-tumor cytotoxicity is mediated via glycogen synthase kinase-3β and β-catenin
L Tao, X Sheng, L Zhang, W Li, Z Wei, P Zhu, F Zhang, A Wang, ...
Biochemical Pharmacology 115, 18-27, 2016
Requisits: Canadian Institutes of Health Research, National Natural Science Foundation …
Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells
L Tao, Y Cao, Z Wei, Q Jia, S Yu, J Zhong, A Wang, JR Woodgett, Y Lu
Toxicology and Applied Pharmacology 337, 85-94, 2017
Requisits: Canadian Institutes of Health Research, National Natural Science Foundation …
GSK-3 mediates nuclear translocation of p62/SQSTM1 in MPTP-induced mouse model of Parkinson’s disease
Y Liu, Q Huang, Z Wei, S Ma, JR Woodgett, M Li, J Li
Neuroscience Letters 763, 136177, 2021
Requisits: Canadian Institutes of Health Research, National Natural Science Foundation …
Glycogen synthase kinase-3 in neurological diseases
O Kaidanovich-Beilin, JR Woodgett
Protein kinase technologies, 153-188, 2012
Requisits: Canadian Institutes of Health Research
Global Approaches to Understanding Protein Kinase Functions
JL Gorman, JR Woodgett
Kinomics: Approaches and Applications, 1-45, 2015
Requisits: Canadian Institutes of Health Research
Disponibles en algun lloc: 93
The ground state of embryonic stem cell self-renewal
QL Ying, J Wray, J Nichols, L Batlle-Morera, B Doble, J Woodgett, ...
nature 453 (7194), 519-523, 2008
Requisits: Canadian Institutes of Health Research
Systematic discovery of in vivo phosphorylation networks
R Linding, LJ Jensen, GJ Ostheimer, MATM van Vugt, C Jørgensen, ...
Cell 129 (7), 1415-1426, 2007
Requisits: Genome Canada
Assessment of social interaction behaviors
O Kaidanovich-Beilin, T Lipina, I Vukobradovic, J Roder, JR Woodgett
Journal of visualized experiments: JoVE, 2473, 2011
Requisits: Canadian Institutes of Health Research
GSK-3: functional insights from cell biology and animal models
O Kaidanovich-Beilin, JR Woodgett
Frontiers in molecular neuroscience 4, 40, 2011
Requisits: Canadian Institutes of Health Research
Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
PTT Ly, Y Wu, H Zou, R Wang, W Zhou, A Kinoshita, M Zhang, Y Yang, ...
The Journal of clinical investigation 123 (1), 2012
Requisits: Canadian Institutes of Health Research
GSK-3 is a master regulator of neural progenitor homeostasis
WY Kim, X Wang, Y Wu, BW Doble, S Patel, JR Woodgett, WD Snider
Nature neuroscience 12 (11), 1390-1397, 2009
Requisits: US National Institutes of Health, Canadian Institutes of Health Research
Tissue-specific role of glycogen synthase kinase 3β in glucose homeostasis and insulin action
S Patel, BW Doble, K MacAulay, EM Sinclair, DJ Drucker, JR Woodgett
Molecular and cellular biology, 2008
Requisits: Canadian Institutes of Health Research
Gsk3 is a metabolic checkpoint regulator in B cells
J Jellusova, MH Cato, JR Apgar, P Ramezani-Rad, CR Leung, C Chen, ...
Nature immunology 18 (3), 303-312, 2017
Requisits: US National Institutes of Health, Canadian Institutes of Health Research …
Deletion of GSK-3β in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation
R Kerkela, L Kockeritz, K MacAulay, J Zhou, BW Doble, C Beahm, ...
The Journal of clinical investigation 118 (11), 3609-3618, 2008
Requisits: US National Institutes of Health, Canadian Institutes of Health Research
Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
O Kaidanovich-Beilin, TV Lipina, K Takao, M Van Eede, S Hattori, ...
Molecular brain 2, 1-23, 2009
Requisits: Canadian Institutes of Health Research
The GSK-3 family as therapeutic target for myocardial diseases
H Lal, F Ahmad, J Woodgett, T Force
Circulation research 116 (1), 138-149, 2015
Requisits: US National Institutes of Health
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression
RL Dillon, R Marcotte, BT Hennessy, JR Woodgett, GB Mills, WJ Muller
Cancer research 69 (12), 5057-5064, 2009
Requisits: US National Institutes of Health, Canadian Institutes of Health Research
Les dades de publicació i de finançament es determinen automàticament per mitjà d'un programa informàtic